Oligometastatic Disease Market To Expand Significantly By 2034, States Delveinsight Report
Oligometastatic Disease Market Forecast DelveInsight's Oligometastatic Disease Market report offers an in-depth understanding of the epidem ...
RAD51 biomarker could complement next-generation sequencing in personalizing prostate cancer treatment
Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...
HealthDay on MSN22h
Improvements in Prostate Cancer Mortality Plateaued From 2012 to 2021
Distant-stage prostate cancer increased and mortality rates plateaued throughout California during the 2010s, according to a ...
New Mexico Cancer Center offers groundbreaking cancer treatments and care
At the New Mexico Cancer Center in Albuquerque, groundbreaking treatments and compassionate care are helping change the lives ...
Cancer Therapy Advisor19h
Acute Toxicity Linked to Late Toxicity After Radiotherapy for Prostate Cancer
Men with prostate cancer are living longer than ever, and our goal is to reduce the risk of late toxicities, such as difficulty urinating or rectal bleeding, that can impact a patient’s quality of ...
The Brighterside of News on MSN5h
New at-home urine test accurately detects prostate cancer
A recent study from researchers at Vanderbilt University and the University of Michigan has demonstrated that a simple at-home urine test can accurately screen for prostate cancer. The findings, ...
“Pushing the Boundaries of Radiation Treatment”: Breakthrough Cancer Therapy Advances to Clinical Trials
A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, potentially improving survival and expanding treatment options. A novel approach ...
Amgen Reports Fourth Quarter And Full Year 2024 Financial Results
Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable ...